how many people are using glp-1 Some 22% of American women and 14% of men have taken GLP-1s for weight loss or for chronic conditions such as diabetes. Rebecca Diamond of Harvard University used data from the Understanding Huge spike in the use

Iron deficiency in heart failure: Screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative project

Bloating, gas, and constipation are common features of irritable bowel syndrome with constipation (IBS-C), which is more prevalent in females

These include methotrexate as first-line therapy, with escalation to combination conventional synthetic DMARDs or biological agents if disease activity remains inadequately controlled

However, there is no evidence that it is less effective at night

Zydus Lifesciences is playing a different game: the Oral Paradigm. While injectables dominate today, the future belongs to oral peptide technology (similar to Rybelsus)